Please try another search
For the nine months ended 30 September 2018, REVA Medical Inc revenues increased from $17K to $237K. Net income increased from $7M to $16.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by General & Administrative expenses increase of 43% to $6.4M (expense), Stock-based Compensation in G&A increase from $1.2M to $2.8M (expense).
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Revenue | 0.09 | 0.09 | 0.05 | 0.03 |
Gross Profit | -0.05 | -0.03 | -0 | -0.01 |
Operating Income | -4.6 | -5.67 | -5.73 | -5.43 |
Net Income | -9.04 | 1.93 | 23.34 | 0.16 |
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Assets | 10.63 | 14.54 | 18.6 | 22.66 |
Total Liabilities | 83.9 | 79.66 | 86.9 | 115.47 |
Total Equity | -73.27 | -65.12 | -68.3 | -92.81 |
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -12.15 | -8.64 | -5.14 | -18.86 |
Cash From Investing Activities | 0.7 | 0.23 | 0.23 | -1.86 |
Cash From Financing Activities | 0 | 0 | 32.58 | |
Net Change in Cash | -11.45 | -8.4 | -4.91 | 11.87 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review